Executives On The Move: New CSOs at Alize and Innovio, Plus Oncology Head at Nektar Therapeutics
Executive Summary
Ipsen VP, Endocrinology is now CSO at metabolic and rare disease Alize Pharma, and cancer and infectious disease firm Innovio Pharmaceuticals promotes R&D leader to CSO. Plus new Head, Oncology at Nektar Therapeutics to lead area strategy.
Source: Medtrack | Informa, 2018